Reuters logo
BRIEF-Genmab: CHMP issues positive opinion recommending DARZALEX (daratumumab)
February 24, 2017 / 12:21 PM / 10 months ago

BRIEF-Genmab: CHMP issues positive opinion recommending DARZALEX (daratumumab)

Feb 24 (Reuters) - Genmab A/S:

* CHMP issued positive opinion for DARZALEX for relapsed or refractory multiple myeloma

* Final decision from European Commission expected in coming months

* Opinion based on data from two Phase III studies, CASTOR and POLLUX Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below